1Young CE, Karas RH, Kuvin JK. High-density lipoprotein cholesterol and coronary heart disease[J]. Cardiology in Review, 2004, 12:107-119.
2Cuchel M, Racier DJ. The role of high density lipoproteins in thrombosis [J]. Scientific World Journal, 2002,2 : 89-95.
3Uittenbogaard A, Shaul PW, Yuhanna IS, et al . High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae [J]. J Biol Chem, 2000,275 : 11278-11283.
4Yuhanna IS, Zhu Y, Cox BE, et al . High-density lipoprotein binding to scavenger receptor-BI activates endothelial nitric oxide synthase[J]. Nat Med, 2001,7:853-857.
5Shaul PW. Endothehal nitric oxide synthase, caveolae and the development of atherosclerosis[J]. J Physiol, 2003,547:21-33.
6Mineo C, Yuharma IS, Quon MJ, et al . High density lipoprotein-induced endothelial nitric-oxide synthase activation is mediated by Akt and MAP kinases[J]. J Biol Chem, 2003,278:9142-9149.
7Cominacini L, Rigoni A, Pasini AF, et al . The binding of oxidized low density lipoprotein (ox-LDL) to ox-LDL receptor-1 reduces the intracellular concentration of nitric oxide in endothelial cells through an increased production of superoxide[J]. J Bid Chem, 2001,276:13750-13755.
8Laura C, Monica G, Guido F. Endothelial protection by high-density lipoproteim: from bench to bedside[J]. Aterioscler Thromb Vasc Biol, 2003,23:1724-1731.
9Tselepis AD, Chapman MJ.Inflammation,bioactive lipids and atherosclerosis:potential roles of a lipoprotein-associated phospholipase A2,platelet activation factor-acetylhydrolase[J].Atheroscler Suppl,2002,3:57-68.
10Griffin JH, Kojima K, Banka CL, et at . High-density lipoprotein enhancement of anticoagulant activities of protein S and activated protein C[J]. J Clin Invest, 1999,103:219-227.
